Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.240
-0.050 (-3.88%)
At close: Jun 30, 2025, 4:00 PM
1.240
0.00 (0.00%)
Pre-market: Jul 1, 2025, 4:41 AM EDT
PACB Market Cap
PACB has a market cap or net worth of $372.11 million as of June 30, 2025. Its market cap has decreased by -31.00% in one year.
Market Cap
372.11M
Enterprise Value
731.11M
1-Year Change
-31.00%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $372.11M, a decrease of -54.84%. That is a compound annual growth rate of -5.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 372.10M | -25.76% |
| Dec 31, 2024 | 501.20M | -80.90% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| Novo Nordisk | 331.06B |
| AbbVie | 322.03B |
| UnitedHealth Group | 280.41B |
| Abbott Laboratories | 233.80B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |